Abel B Quaresma1, Gilaad G Kaplan, Paulo G Kotze. 1. aWest Santa Catarina State University (UNOESC), Joaçaba, Brazil bUniversity of Calgary, Calgary, Alberta, Canada cCatholic University of Paraná (PUCPR), Curitiba, Brazil.
Abstract
PURPOSE OF REVIEW: Epidemiological studies of inflammatory bowel disease (IBD) in newly industrialized countries are limited, due to a lack of medical surveillance systems and reliable and unified registries and databases. In Brazil, reliable data on the incidence and prevalence of Crohn's disease and ulcerative colitis is scarce. The objective of the present review is to describe in detail the available data on the incidence and prevalence of Crohn's disease and ulcerative colitis in Brazil. RECENT FINDINGS: The authors identified the single four population-based studies which refer to incidence and prevalence of IBD in the country (two from São Paulo, one from Espírito Santo and one from the state of Piauí). These studies demonstrate a remarkable growth in the incidence and estimated prevalence of IBD in Brazil, with higher number of cases in more developed regions. SUMMARY: The increase in incidence over time and the higher current prevalence are indicative of a historical progression in relation to the number of IBD patients in our country, similar to what was observed in countries from Asia and approximating those of the northern hemisphere. Epidemiological studies with more accurate methodology are needed in Brazil.
PURPOSE OF REVIEW: Epidemiological studies of inflammatory bowel disease (IBD) in newly industrialized countries are limited, due to a lack of medical surveillance systems and reliable and unified registries and databases. In Brazil, reliable data on the incidence and prevalence of Crohn's disease and ulcerative colitis is scarce. The objective of the present review is to describe in detail the available data on the incidence and prevalence of Crohn's disease and ulcerative colitis in Brazil. RECENT FINDINGS: The authors identified the single four population-based studies which refer to incidence and prevalence of IBD in the country (two from São Paulo, one from Espírito Santo and one from the state of Piauí). These studies demonstrate a remarkable growth in the incidence and estimated prevalence of IBD in Brazil, with higher number of cases in more developed regions. SUMMARY: The increase in incidence over time and the higher current prevalence are indicative of a historical progression in relation to the number of IBD patients in our country, similar to what was observed in countries from Asia and approximating those of the northern hemisphere. Epidemiological studies with more accurate methodology are needed in Brazil.
Authors: Sandro da Costa Ferreira; Lilian Rose Otoboni Aprile; Rogério Serafim Parra; Marley Ribeiro Feitosa; Gleici de Castro da Silva Perdoná; Omar Féres; José Joaquim Ribeiro da Rocha; Luiz Ernesto de Almeida Troncon Journal: Turk J Gastroenterol Date: 2022-04 Impact factor: 1.555
Authors: Cyrla Zaltman; Rogério Serafim Parra; Ligia Yukie Sassaki; Genoile Oliveira Santana; Maria de Lourdes Abreu Ferrari; Sender J Miszputen; Heda M B S Amarante; Roberto Luiz Kaiser Junior; Cristina Flores; Wilson R Catapani; José Miguel Luz Parente; Mauro Bafutto; Odery Ramos; Carolina D Gonçalves; Isabella Miranda Guimaraes; Jose J R da Rocha; Marley R Feitosa; Omar Feres; Rogerio Saad-Hossne; Francisco Guilherme Cancela Penna; Pedro Ferrari Sales Cunha; Tarcia Nf Gomes; Rodrigo Bremer Nones; Mikaell Alexandre Gouvea Faria; Mírian Perpétua Palha Dias Parente; António S Scotton; Rosana Fusaro Caratin; Juliana Senra; Júlio Maria Chebli Journal: World J Gastroenterol Date: 2021-01-14 Impact factor: 5.742